Radiation dose to laterally transposed ovaries during external beam radiotherapy for cervical cancer. 2006

Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
Department of Medical Physics, University Hospital of Iraklion, Iraklion, Crete, Greece. mazonak@med.uoc.gr

The purpose of this study was to estimate the radiation dose to laterally transposed ovaries from external beam radiotherapy for cervical cancer. Dose measurements were performed in a modified humanoid phantom using a 6 MV photon beam. The dependence of the ovarian dose upon the field size, the distance from the primary irradiation field and the presence of wedges or gonadal shielding was determined. For a tumor dose of 45 Gy, ovarian dose was 0.88-8.51 Gy depending on the field size employed and the location of the transposed ovary in respect to the treatment field. Positioning of 7 cm thick shielding reduced the dose to ovary by less than 19%. The use of wedges increased the ovarian dose by a factor up to 1.5. Accurate radiographic localization of the ovaries allows the use of the presented dosimetric results to obtain a reasonable prediction of the ovarian dose.

UI MeSH Term Description Entries
D008953 Models, Anatomic Three-dimensional representation to show anatomic structures. Models may be used in place of intact animals or organisms for teaching, practice, and study. Anatomic Models,Models, Surgical,Moulages,Models, Anatomical,Anatomic Model,Anatomical Model,Anatomical Models,Model, Anatomic,Model, Anatomical,Model, Surgical,Moulage,Surgical Model,Surgical Models
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D011835 Radiation Protection Methods and practices adopted to protect against RADIATION. Protection, Radiation
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
January 2019, Physics and imaging in radiation oncology,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
August 2023, Acta oncologica (Stockholm, Sweden),
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
September 2008, The Journal of the Arkansas Medical Society,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
July 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
December 1997, International journal of radiation oncology, biology, physics,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
May 2019, Physics in medicine and biology,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
December 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
January 2020, American journal of clinical oncology,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
January 1999, Radiation oncology investigations,
Michael Mazonakis, and John Damilakis, and Haris Varveris, and Nicholas Gourtsoyiannis
September 2010, Panminerva medica,
Copied contents to your clipboard!